116 related articles for article (PubMed ID: 9168997)
1. Changes in BRCA2 expression during progression of the cell cycle.
Wang SC; Lin SH; Su LK; Hung MC
Biochem Biophys Res Commun; 1997 May; 234(1):247-51. PubMed ID: 9168997
[TBL] [Abstract][Full Text] [Related]
2. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle control of BRCA2.
Vaughn JP; Cirisano FD; Huper G; Berchuck A; Futreal PA; Marks JR; Iglehart JD
Cancer Res; 1996 Oct; 56(20):4590-4. PubMed ID: 8840967
[TBL] [Abstract][Full Text] [Related]
4. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ
Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH
Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
8. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression.
Su LK; Wang SC; Qi Y; Luo W; Hung MC; Lin SH
Oncogene; 1998 Nov; 17(18):2377-81. PubMed ID: 9811469
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen.
Spillman MA; Bowcock AM
Oncogene; 1996 Oct; 13(8):1639-45. PubMed ID: 8895509
[TBL] [Abstract][Full Text] [Related]
10. The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression.
Chalabi N; Le Corre L; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
Eur J Cancer; 2004 Jul; 40(11):1768-75. PubMed ID: 15251168
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn JP; Davis PL; Jarboe MD; Huper G; Evans AC; Wiseman RW; Berchuck A; Iglehart JD; Futreal PA; Marks JR
Cell Growth Differ; 1996 Jun; 7(6):711-5. PubMed ID: 8780884
[TBL] [Abstract][Full Text] [Related]
14. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.
Blackshear PE; Goldsworthy SM; Foley JF; McAllister KA; Bennett LM; Collins NK; Bunch DO; Brown P; Wiseman RW; Davis BJ
Oncogene; 1998 Jan; 16(1):61-8. PubMed ID: 9467943
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.
Kronenwett U; Castro J; Roblick UJ; Fujioka K; Ostring C; Faridmoghaddam F; Laytragoon-Lewin N; Tribukait B; Auer G
BMC Cell Biol; 2003 Jul; 4():8. PubMed ID: 12875657
[TBL] [Abstract][Full Text] [Related]
16. Regulation of MCP-3 and BRCA2 mRNA expression levels by beta(1) integrins.
Moro L; Fornaro M; Steger CA; Languino LR
Exp Mol Pathol; 2001 Jun; 70(3):239-47. PubMed ID: 11418002
[TBL] [Abstract][Full Text] [Related]
17. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
19. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from BRCA1 and BRCA2.
Zheng L; Li S; Boyer TG; Lee WH
Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
